Xilio Therapeutics (NASDAQ:XLO) Upgraded by Wall Street Zen to “Buy” Rating
Wall Street Zen upgraded shares of Xilio Therapeutics (NASDAQ:XLO – Free Report) from a hold rating to a buy rating in a report published on Thursday. Xilio Therapeutics Stock Performance NASDAQ:XLO opened at $0.88 on Thursday. The firm has a market cap of $45.76 million, a price-to-earnings ratio of -0.51 and a beta of -0.27. […]
Wall Street Zen upgraded shares of Xilio Therapeutics (NASDAQ:XLO – Free Report) from a hold rating to a buy rating in a report published on Thursday. Xilio Therapeutics Stock Performance NASDAQ:XLO opened at $0.88 on Thursday. The firm has a market cap of $45.76 million, a price-to-earnings ratio of -0.51 and a beta of -0.27. […]
